中文 English

PlasAim® Targeted Non-invasive Digital PCR Detection Array

Detection method

Digital PCR has a higher sensitivity than sequencing and conventional PCR.

Test significance

To guide the targeted drug therapy of lung cancer EGFR-TKI.

Product advantage

- High sensitivity: The lowest sensitivity can reach 1/10,000, suitable for the detection of trace ctDNA in the blood.

- Accurate results:The overall compliance rate of digital PCR for blood EGFR 19del/L858R/T790M detection is higher than other methods.

- Absolute quantification:Multiple detections can monitor the variation of mutation site abundance and quickly detect the disease progression. Thus the treatment plan can be adjusted.

Detection of genes

Tumor genes(3)

  • 19del
  • L858R
  • T790M

Applicable to cancer patients

Applicable to lung cancer patients, supports EGFR-TKIs drug clinical treatment decisions.

Test procedure

*Product is for research use only.